Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer
Sponsors and Collaborators
Columbia University
Celgene Corporation
Contact
Sam Cammack
212-305-1207
ac2239@columbia.edu
Principal Investigator
James M McKiernan, MD, Columbia University Medical Center, Urology
ClinicalTrials.gov Identifier
NCT00583349